Page last updated: 2024-08-24

fadrozole and abiraterone

fadrozole has been researched along with abiraterone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hartmann, RW; Hu, Q; Kazmaier, U; Lucas, S; Maurer, F; Yin, L1
Belluti, F; Bisi, A; Gobbi, S; Hartmann, RW; Hu, Q; Negri, M; Rampa, A; Zimmer, C1
Engel, M; Hartmann, RW; Hu, Q; Pinto-Bazurco Mendieta, MA1

Other Studies

3 other study(ies) available for fadrozole and abiraterone

ArticleYear
Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndrome.
    Journal of medicinal chemistry, 2012, Jul-26, Volume: 55, Issue:14

    Topics: Animals; Aromatase; Cushing Syndrome; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Humans; Imidazoles; Inhibitory Concentration 50; Quinolones; Rats; Stereoisomerism; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase; Substrate Specificity

2012
Modulation of cytochromes P450 with xanthone-based molecules: from aromatase to aldosterone synthase and steroid 11β-hydroxylase inhibition.
    Journal of medicinal chemistry, 2013, Feb-28, Volume: 56, Issue:4

    Topics: Animals; Aromatase Inhibitors; Cricetinae; Cytochrome P-450 CYP11B2; Fibroblasts; Humans; Imidazoles; Models, Molecular; Small Molecule Libraries; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase; Structure-Activity Relationship; Xanthones

2013
Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseases.
    Journal of medicinal chemistry, 2013, Aug-08, Volume: 56, Issue:15

    Topics: Antineoplastic Agents; Cardiovascular Diseases; Cell Line; Cytochrome P-450 CYP11B2; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Humans; Male; Models, Molecular; Naphthalenes; Prostatic Neoplasms; Pyridines; Steroid 11-beta-Hydroxylase; Steroid 17-alpha-Hydroxylase

2013